About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AGRX - Agile Therapeutics| Previous Close | $3.02 | Open | $3.05 |
| Volume | 326.9K | Market Cap | 269.3M |
| Yield | Last Dividend |
| Contraceptive Devices Market Projected t... | 10/07/20 |
| Global Contraceptive Devices Market Analysis to 2025 is a specialized and in-depth study of the Contraceptive Devices industry with a focus on the glo... | |
| Agile Therapeutics Announces Virtual Inv... | 09/08/20 |
| Company to Present Twirla?? Commercial Plan Webcast Scheduled from 11:00 am ??? 1:00 pm EDT PRINCETON, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile?... | |
| Is the Options Market Predicting a Spike... | 05/07/20 |
| Investors need to pay close attention to Agile Therapeutics (AGRX) stock based on the movements in the options market lately. | |
| Agile Therapeutics Reports First Quarter... | 05/05/20 |
| FDA Approved Twirla?? Expected to Reach Wholesalers in the Fourth Quarter of 2020 $93.9 Million in Cash and Cash Equivalents as of March 31, 2020 ??? | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| Is Agile Therapeutics (AGRX) Stock Outpa... | 02/21/20 |
| Is (AGRX) Outperforming Other Medical Stocks This Year? | |
| Agile Therapeutics EPS misses by $0.02 | 02/20/20 |
| Agile Therapeutics (NASDAQ:AGRX): Q4 GAAP EPS of -$0.10 misses by $0.02. Cash and equivalents of $34.5M. Shares -14.3%. Press Release | |
| Agile Therapeutics Reports Fourth Quarte... | 02/20/20 |
| Current Cash and Cash Equivalents Expected to Meet Projected Operating Requirements through End of 2020 Twirla??, Company???s Lead Product Candidate,?... | |
| Why This Analyst Sees New Contraceptive ... | 02/18/20 |
| No summary available. | |
| The Week Ahead In Biotech: Agile, Baudax... | 02/16/20 |
| Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies... | |
| The Daily Biotech Pulse: Deciphera Cance... | 02/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) ... | |
| The Daily Biotech Pulse: J&J Intensifies... | 02/12/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) ... | |
| Stock Alert: Agile Therapeutics (AGRX) | 02/11/20 |
| Shares of Agile Therapeutics, Inc. (AGRX) continue to hit new highs as the Company gears up for a major regulatory catalyst this week.. | |
| Agile Finalizes $35M Term Loan Facility ... | 02/11/20 |
| Agile Therapeutics Inc (NASDAQ: AGRX ) shares are advancing Tuesday after the company announced clinching of a term loan facility. The micro-cap biote... | |
| Attention Biotech Investors: Mark Your C... | 02/03/20 |
| Biotech stocks have come under some selling pressure in the new year. However, January did witness some strong stock-specific upward moves, especially... | |
| The Daily Biotech Pulse: Sanofi Reports ... | 01/30/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) ... | |
| The Daily Biotech Pulse: Novartis Earnin... | 01/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 28) ... | |
| Agile Therapeutics: 400%+ Upside | 01/22/20 |
| Agile Therapeutics, Inc. is a ~$160 million market capitalization pre-revenue biotech company. The company's lead product, the Twirla contraceptive pa... | |
| Over 400% Potential Upside With Agile Th... | 01/22/20 |
| Agile Therapeutics, Inc. is a ~$160 million market capitalization pre-revenue biotech company.The company's lead product, the Twirla contraceptive pat... | |
| The Daily Biotech Pulse: Xeris Jumps On ... | 01/07/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Acorda Surges A... | 01/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) A... | |
| Hedge Funds Have Never Been More Bullish... | 12/14/19 |
| Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Faceb... | |
| Brokerages Set Agile Therapeutics Inc (N... | 11/17/19 |
| Agile Therapeutics Inc (NASDAQ:AGRX) has earned a consensus rating of ???Buy??? from the eight ratings firms that are covering the company, Marketbeat... | |
| Agile Therapeutics Announces FDA Extensi... | 11/14/19 |
| Agile Therapeutics, Inc. (AGRX), a women???s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has extended the Pre... | |
| The Daily Biotech Pulse: Obseva Sinks On... | 11/07/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 6) A... | |
| The Daily Biotech Pulse: FDA Nod For San... | 11/05/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 4) A... | |
| Agile Therapeutics (AGRX) Stock Continue... | 11/04/19 |
| Agile Therapeutics Inc (NASDAQ: AGRX) is running for the top in the market today, following up on the gains that we???ve seen from the stock since Wed... | |
| Agile Therapeutics Rallies After FDA Pan... | 10/31/19 |
| Agile Therapeutics Inc (NASDAQ: AGRX ) shares were galloping higher Thursday in a notable turnaround following the precipitous drop they experienced e... | |
| The Daily Biotech Pulse: Mirati Tastes S... | 10/29/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs O... | |
| The Zacks Analyst Blog Highlights: Barre... | 10/01/19 |
| The Zacks Analyst Blog Highlights: Barrett Business Services, Hibbett Sports, Construction Partners, Agile Therapeutics and Boot Barn | |
| Date | 2020-08-11 (BMO) | Est. (EPS/Rev.) | ($0.14)/ 0 |
| Actual (EPS/Rev.) | $-0.12/ | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Tech Trades | Tech Trades | 82.00 % | Follow |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 66.00 % | Follow |
| R R Investments | Roland Van Rij | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
